Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Verleye, A. Wijtvliet, V. Abrams, S. Hellemans, R. Bougrea, R. Massart, A. Pipeleers, L. Wissing, K. M. Ariën, K. K. De Winter, B. Y. Van Damme, P. Abramowicz, D. Ledeganck, K. J.
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis
Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Corti, C. Antonarelli, G. Scotté, F. Spano, J. P. Barrière, J. Michot, J. M. André, F. Curigliano, G.
Seroconversion rate after vaccination against COVID-19 in patients with cancer - a systematic review
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Ramli, N. S. Ismail, N. M. Zaini, N. Hayati, F. Jeffree, M. S. Rahim, S. S. S. A. Hassan, M. R.
Seroepidemiological Studies on Japanese Encephalitis: A Systematic Review
South-East Asia All age groups Japanese encephalitis Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Ge, C. Du, K. Luo, M. Shen, K. Zhou, Y. Guo, K. Liu, Y. Yin, C. Li, Y. Li, G. Chen, X.
Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Sakuraba, A. Luna, A. Micic, D.
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Chen, D. Pan, Y. Wang, Y. Chen, X. Zhang, J. Zhang, Y. Ding, T. Yang, Z. Lu, T. Zheng, Y. Wei, J. Kong, W. Li, H. Yin, X. Yang, G. Zhang, G. Wang, X.
Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Auroux, Maxime Laurent, Benjamin Coste, Baptiste Massy, Emmanuel Mercier, Alexandre Durieu, Isabelle Confavreux, Cyrille B. Lega, Jean-Christophe Mainbourg, Sabine Coury, Fabienne
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: a cohort study and a systematic review with meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Bonkat, N. Fellendorf, F. T. Dalkner, N. Reininghaus, E. Z.
Severe mental disorders and vaccinations - a systematic review
Adolescents Adults Older adults Pregnant women Coverage Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ MarraMs, Alexandre R. M. D. Kobayashi, Takaaki Suzuki, Hiroyuki Alsuhaibani, Mohammed Tofaneto, Bruna Marques Bariani, Luigi Makowski Auler, Mariana de Amorim Salinas, Jorge L. Edmond, Michael B. Doll, Michelle Kutner, José Mauro Pinho, João Renato Rebello Rizzo, Luiz Vicente Miraglia, João Luiz Schweizer, Marin L.
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2022 ∙ Lin, Kan Huang, Huayao Fang, Shuangfang Zheng, Guanyi Fu, Kailong Liu, Nan Du, Houwei
Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis
All age groups Parents/caregivers COVID-19 Coverage Safety Acceptance
Rating:
Critically low
Loading...